Home > Healthcare > Biotechnology > Biotechnology R&D > Non-animal Alternative Testing Market

Non-animal Alternative Testing Market Share

Report ID: GMI5704
Published Date: May 2023
Report Format: PDF

Download Free Sample

Non-animal Alternative Testing Market Share

The global non-animal alternative testing industry comprises several players including :

AlveoliX AG,
MIMETAS
MatTek Corporatio
Emulate, Inc
VITROCELL Systems GmbH
Bio-Rad Laboratories, Inc.
Hurel Corporation
Evotec SE
MB Research Laboratories
TissUse GmbH.

These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches, etc. to maintain a competitive edge in the industry.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for non-animal alternative testing was valued at USD 1,725.0 million in 2022 and is expected to surpass USD 4,534.2 million by 2032 at 10.3% CAGR attributed to the rising emphasis on animal welfare.

The cell culture technology segment generated USD 746.9 million in 2022 and is anticipated to grow at a steady pace through 2032 owing to its extensive use by researchers for analyzing many test results simultaneously.

The North America non-animal alternative testing market amassed USD 653.8 million in 2022 and is poised to grow at 8.2% CAGR through 2032 due to the presence of key players in the region.

AlveoliX AG, MIMETAS, MatTek Corporation, Emulate, Inc, VITROCELL Systems GmbH, Bio-Rad Laboratories, Inc., Hurel Corporation, Evotec SE, MB Research Laboratories, and TissUse GmbH are the prominent companies in the market.